Global Health Information & Medical Research Institute
Virus/Disease:
AIDS/HIV
Product:
High Potency Silvicidal also referred to as "CellStat HIV"
Under Construction
Patient 252 had a viral load above 100,000 with the HIV related viruses Herpes and Hepatitis B. He was given the same protocol as patient 251. At the beginning of the trial this patient had an outbreak of Herpes and refused to change his lifestyle. Within 30 days of the High Potency Silvicidal infusion, his viral load dropped 65% and then started to increase. The consensus was that the CellStat HIV could not kill off HIV, herpes and Hepatitis B all at the same time with one major infusion. No side effects were noted. Patient 252 was feeling so well he took on two jobs and showed no outward signs of HIV. A decision to do a second infusion was made. He was sent to his medical doctor for a full check up prior to the second infusion. His doctor reported no symptoms of HIV. Patient 252 could not be located to receive the second infusion. Due to the fact that this patient refused to change his lifestyle and could have been re-infected at any time, he was going to be terminated from the trial. The patient believed he was cured of HIV even though he was advised there were no such indications.